EP1429789A2 - Antiinfektive kohlenhydrate - Google Patents
Antiinfektive kohlenhydrateInfo
- Publication number
- EP1429789A2 EP1429789A2 EP02800120A EP02800120A EP1429789A2 EP 1429789 A2 EP1429789 A2 EP 1429789A2 EP 02800120 A EP02800120 A EP 02800120A EP 02800120 A EP02800120 A EP 02800120A EP 1429789 A2 EP1429789 A2 EP 1429789A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- hexnac
- gal
- unit
- pathogens
- terminal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Definitions
- An effervescent tablet (final weight 4.15 g) (Neovin® from Milupa,) is produced in a manner known per se with the addition of 200 to 500 mg LNFP I. One tablet is dissolved and drunk in 150 ml of water every day.
- Example 4 Product for the elderly and the weakened
- a baby milk formula (Aptamil® from Milupa) with 11.8 g of protein, 56.9 g of carbohydrates, 24.9 g of fat, 2.5 g of minerals, vitamins and 45 mg of taurine is produced in the form of a pearlate in the usual way, which is mixed with 100 mg to 1000 mg LNFP I per 100 g of baby milk.
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08008842A EP1970065A1 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive Kohlenhydrate |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10147100A DE10147100A1 (de) | 2001-09-25 | 2001-09-25 | Antiinfektive Kohlenhydrate |
DE10147100 | 2001-09-25 | ||
PCT/EP2002/010761 WO2003028738A2 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive kohlenhydrate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08008842A Division EP1970065A1 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive Kohlenhydrate |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1429789A2 true EP1429789A2 (de) | 2004-06-23 |
EP1429789B1 EP1429789B1 (de) | 2008-05-14 |
Family
ID=7700136
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02800120A Expired - Lifetime EP1429789B1 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive kohlenhydrate |
EP08008842A Withdrawn EP1970065A1 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive Kohlenhydrate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08008842A Withdrawn EP1970065A1 (de) | 2001-09-25 | 2002-09-25 | Antiinfektive Kohlenhydrate |
Country Status (6)
Country | Link |
---|---|
US (1) | US7858595B2 (de) |
EP (2) | EP1429789B1 (de) |
AT (1) | ATE395066T1 (de) |
DE (2) | DE10147100A1 (de) |
ES (1) | ES2306811T3 (de) |
WO (1) | WO2003028738A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1629850B2 (de) | 2004-08-24 | 2013-05-22 | N.V. Nutricia | Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält |
CN101420966B (zh) * | 2006-03-10 | 2013-07-17 | 纽崔西亚公司 | 不可消化的糖用于在出生后给予婴儿最佳开始的用途 |
EP2060257A1 (de) * | 2007-11-08 | 2009-05-20 | Nestec S.A. | Vorbeugung und Behandlung von Sekundärinfektionen nach Virusinfektion |
CA2705014A1 (en) * | 2007-11-08 | 2009-05-14 | Nestec S.A. | Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
CN103402376A (zh) | 2010-12-31 | 2013-11-20 | 雅培制药有限公司 | 促进有益细菌生长的中性人乳寡糖 |
NZ613180A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
EP2658548B1 (de) | 2010-12-31 | 2018-02-21 | Abbott Laboratories | Oligosaccharide aus muttermilch zur modulierung von entzündungen |
MX352040B (es) | 2010-12-31 | 2017-11-07 | Abbott Lab | Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. |
SG191395A1 (en) | 2010-12-31 | 2013-08-30 | Abbott Lab | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
SG10202110501RA (en) | 2010-12-31 | 2021-11-29 | Abbott Lab | Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides |
MY180910A (en) | 2010-12-31 | 2020-12-11 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
WO2012106662A2 (en) * | 2011-02-04 | 2012-08-09 | The Regents Of The University Of California | New agents to treat/prevent amoebiasis |
ES2657744T3 (es) | 2011-07-22 | 2018-03-06 | Abbott Laboratories | Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal |
NL2007268C2 (en) * | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
MY186844A (en) | 2014-07-09 | 2021-08-25 | Cadena Bio Inc | Oligosaccharide compositions and methods for producing thereof |
ES2755042T3 (es) | 2015-01-26 | 2020-04-21 | Cadena Bio Inc | Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas |
AU2016212030B2 (en) | 2015-01-26 | 2021-06-17 | Kaleido Biosciences, Inc. | Glycan therapeutics and related methods thereof |
EP3285778A2 (de) * | 2015-04-23 | 2018-02-28 | Kaleido Biosciences, Inc. | Mikrobiomregler und zugehörige verfahren davon |
JP2018517677A (ja) | 2015-04-23 | 2018-07-05 | カレイド・バイオサイエンシズ・インコーポレイテッド | グリカン治療剤及び治療方法 |
US20180235987A1 (en) * | 2015-08-25 | 2018-08-23 | Kaleido Biosciences, Inc. | Glycan compositions and uses thereof |
JP2019510037A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | 抗菌ペプチド刺激性洗浄組成物 |
JP2019515886A (ja) * | 2016-03-31 | 2019-06-13 | ゴジョ・インダストリーズ・インコーポレイテッド | 病原体結合を減少させるための局所用組成物 |
AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
EP3877424A2 (de) | 2018-11-08 | 2021-09-15 | Kaleido Biosciences, Inc. | Oligosaccharidzusammensetzungen und verfahren zur verwendung davon |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1261264A (en) * | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
WO1990010870A1 (en) * | 1989-03-01 | 1990-09-20 | Cornell Research Foundation, Inc. | Development of a monoclonal antibody based detection system for listeria monocytogenes |
GB9215768D0 (en) | 1992-07-24 | 1992-09-09 | Agricultural & Food Res | Repression of virulent gene expression |
WO1994018986A1 (en) * | 1993-02-26 | 1994-09-01 | Jan Staffan Normark | Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
JPH0838064A (ja) * | 1994-07-26 | 1996-02-13 | Meiji Seika Kaisha Ltd | 有害細菌の感染を予防する飼料 |
DE19701382A1 (de) * | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
DE10104055A1 (de) * | 2001-01-31 | 2002-08-14 | Suedzucker Ag | Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren |
-
2001
- 2001-09-25 DE DE10147100A patent/DE10147100A1/de not_active Withdrawn
-
2002
- 2002-09-25 DE DE50212276T patent/DE50212276D1/de not_active Expired - Lifetime
- 2002-09-25 ES ES02800120T patent/ES2306811T3/es not_active Expired - Lifetime
- 2002-09-25 WO PCT/EP2002/010761 patent/WO2003028738A2/de active IP Right Grant
- 2002-09-25 US US10/490,102 patent/US7858595B2/en not_active Expired - Fee Related
- 2002-09-25 EP EP02800120A patent/EP1429789B1/de not_active Expired - Lifetime
- 2002-09-25 EP EP08008842A patent/EP1970065A1/de not_active Withdrawn
- 2002-09-25 AT AT02800120T patent/ATE395066T1/de not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO03028738A2 * |
Also Published As
Publication number | Publication date |
---|---|
ATE395066T1 (de) | 2008-05-15 |
EP1970065A1 (de) | 2008-09-17 |
EP1429789B1 (de) | 2008-05-14 |
WO2003028738A3 (de) | 2003-08-21 |
US7858595B2 (en) | 2010-12-28 |
DE50212276D1 (de) | 2008-06-26 |
US20050004070A1 (en) | 2005-01-06 |
ES2306811T3 (es) | 2008-11-16 |
DE10147100A1 (de) | 2003-04-17 |
WO2003028738A2 (de) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1429789B1 (de) | Antiinfektive kohlenhydrate | |
EP1105002B9 (de) | Kohlenhydratmischungen | |
DE60107544T2 (de) | Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort | |
DE69916288T2 (de) | Lipasehemmer und chitosan enthaltende arzneimittel | |
US5705184A (en) | Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses | |
DE69530910T4 (de) | Medizinische zusammensetzungen enthaltend ein sialinsäurederivat | |
DE60034667T2 (de) | Pharmazeutische zusammensetzung aus komplexen kohlenhydraten und deren anwendung | |
DE69917784T2 (de) | Flüssige chitosan-enthaltende zusammensetzungen und verfahren zur herstellung und verwendung | |
DE60118019T2 (de) | Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung | |
DE10006989A1 (de) | Antiadhäsive Kohlenhydratmischung | |
DE69733089T2 (de) | Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin | |
EP2473175B1 (de) | Verwendung von nichtverdaulichen oligosacchariden | |
EP1357917B9 (de) | Verwendung von kohlenhydraten zur beseitigung von darminfektionen bei tieren | |
DE60104977T2 (de) | Glucosamin enthaltende Neutrophil-Funktionshemmer | |
EP1469866B1 (de) | Cycloglycane geeignet zur verhinderung der infektion von säugetierzellen | |
DE3424997C2 (de) | ||
DE60114724T2 (de) | Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose | |
DE3341760C2 (de) | ||
DE69838076T2 (de) | Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz | |
WO2008012089A2 (de) | Polyphenol-peptid-zusammensetzung und ihre verwendung zur unterstützung der darmgesundheit | |
JP2000157210A (ja) | myo−イノシトールとキトサンの健康食品組成物 | |
DE4005159A1 (de) | Diterpene mit immunmodulatorischer wirkung | |
WO2002047695A1 (de) | Blockierung der anlagerung von keimen bei vögeln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040330 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17Q | First examination report despatched |
Effective date: 20050502 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50212276 Country of ref document: DE Date of ref document: 20080626 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: TROESCH SCHEIDEGGER WERNER AG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2306811 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080814 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20081014 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
BERE | Be: lapsed |
Owner name: N.V. NUTRICIA Effective date: 20080930 |
|
26N | No opposition filed |
Effective date: 20090217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080930 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080814 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080925 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080514 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080925 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080815 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20110926 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20120920 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20120919 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20120925 Year of fee payment: 11 Ref country code: ES Payment date: 20120924 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20120920 Year of fee payment: 11 Ref country code: DE Payment date: 20121030 Year of fee payment: 11 Ref country code: FR Payment date: 20121008 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20140401 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20130925 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50212276 Country of ref document: DE Effective date: 20140401 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20140530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130925 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130930 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140401 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130925 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140401 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20141007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130926 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130925 |